Literature DB >> 20074462

HLA-A*01 is associated with late onset of Alzheimer's disease in Italian patients.

F R Guerini1, C Tinelli, E Calabrese, C Agliardi, M Zanzottera, A De Silvestri, M Franceschi, L M E Grimaldi, R Nemni, M Clerici.   

Abstract

In this study, the distribution of HLA-A alleles was analyzed in Italian Alzheimer's Disease (AD)patients. Interaction between HLA alleles, APOE genotypes, age of onset, and gender were also analyzed. The results were compared to those obtained in healthy controls (HC). One hundred-seventy-three AD patients and 258 age-and-sex-matched healthy controls were enrolled in the study. AD patients were classified according to age at the onset of disease using quartiles of the distribution. HLA-A genotyping was performed by PCR-SSP; APOE genotyping was performed by RFLP. A correlation between late disease onset and HLA-A*01 was observed. Thus, HLA-A*01, calculated as number of alleles, was significantly more present in patients with age of onset > 74.0 years than in HC (20% vs 10.5%; p=0.014); the distribution of this allele was skewed also in patients 68.1-74 years of age (16.3%), even if the difference did not reach statistical significance. The relative risk ratio (RRR) of AD onset calculated by a multinomial logistic regression adjusted for sex and presence of APOE-4 confirmed a significant association of HLA-A*01 with AD onset > 74.0 years of age (RRR=2.2; 95%CI: 1.1-4.6; p=0.033). A high RRR (2.04) was also present in patients 68.1-74 years (p=0.064). Lower age of disease onset did not correlate with HLA-A*01. Data herein suggest that the presence of HLA-A*01 results in delayed AD development, even in patients carrying APOE-4. These results could offer new insights into the etiopathogenesis of Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20074462     DOI: 10.1177/039463200902200414

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN: 0394-6320            Impact factor:   3.219


  11 in total

1.  An Efficient Nonlinear Regression Approach for Genome-wide Detection of Marginal and Interacting Genetic Variations.

Authors:  Seunghak Lee; Aurélie Lozano; Prabhanjan Kambadur; Eric P Xing
Journal:  J Comput Biol       Date:  2016-05       Impact factor: 1.479

2.  A novel single cDNA amplicon pyrosequencing method for high-throughput, cost-effective sequence-based HLA class I genotyping.

Authors:  Simon M Lank; Roger W Wiseman; Dawn M Dudley; David H O'Connor
Journal:  Hum Immunol       Date:  2010-07-30       Impact factor: 2.850

3.  Genomics of Dementia: APOE- and CYP2D6-Related Pharmacogenetics.

Authors:  Ramón Cacabelos; Rocío Martínez; Lucía Fernández-Novoa; Juan C Carril; Valter Lombardi; Iván Carrera; Lola Corzo; Iván Tellado; Jerzy Leszek; Adam McKay; Masatoshi Takeda
Journal:  Int J Alzheimers Dis       Date:  2012-03-14

4.  HLA-A2 Alleles Mediate Alzheimer's Disease by Altering Hippocampal Volume.

Authors:  Zi-Xuan Wang; Hui-Fu Wang; Lin Tan; Fu-Rong Sun; Meng-Shan Tan; Chen-Chen Tan; Teng Jiang; Lan Tan; Jin-Tai Yu
Journal:  Mol Neurobiol       Date:  2016-03-15       Impact factor: 5.590

5.  Alzheimer's disease and HLA-A2: linking neurodegenerative to immune processes through an in silico approach.

Authors:  Ricardo A Cifuentes; Juan Murillo-Rojas
Journal:  Biomed Res Int       Date:  2014-08-17       Impact factor: 3.411

6.  Fine-mapping of the human leukocyte antigen locus as a risk factor for Alzheimer disease: A case-control study.

Authors:  Natasha Z R Steele; Jessie S Carr; Luke W Bonham; Ethan G Geier; Vincent Damotte; Zachary A Miller; Rahul S Desikan; Kevin L Boehme; Shubhabrata Mukherjee; Paul K Crane; John S K Kauwe; Joel H Kramer; Bruce L Miller; Giovanni Coppola; Jill A Hollenbach; Yadong Huang; Jennifer S Yokoyama
Journal:  PLoS Med       Date:  2017-03-28       Impact factor: 11.069

7.  HLA-DRB1 alleles are associated with the susceptibility to sporadic Parkinson's disease in Chinese Han population.

Authors:  Congcong Sun; Lei Wei; Feifei Luo; Yi Li; Jiaobiao Li; Feiqi Zhu; Ping Kang; Rensi Xu; Lulu Xiao; Zhuolin Liu; Pingyi Xu
Journal:  PLoS One       Date:  2012-11-06       Impact factor: 3.240

8.  Analysis of copy number variation in Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals.

Authors:  Shanker Swaminathan; Matthew J Huentelman; Jason J Corneveaux; Amanda J Myers; Kelley M Faber; Tatiana Foroud; Richard Mayeux; Li Shen; Sungeun Kim; Mari Turk; John Hardy; Eric M Reiman; Andrew J Saykin
Journal:  PLoS One       Date:  2012-12-05       Impact factor: 3.240

9.  Major Histocompatibility Complex class I proteins are critical for maintaining neuronal structural complexity in the aging brain.

Authors:  Maciej J Lazarczyk; Julia E Kemmler; Brett A Eyford; Jennifer A Short; Merina Varghese; Allison Sowa; Daniel R Dickstein; Frank J Yuk; Rishi Puri; Kaan E Biron; Marcel Leist; Wilfred A Jefferies; Dara L Dickstein
Journal:  Sci Rep       Date:  2016-05-27       Impact factor: 4.379

10.  Association of HLA-DRB1 polymorphism with Alzheimer's disease: a replication and meta-analysis.

Authors:  Rui-Chun Lu; Wu Yang; Lin Tan; Fu-Rong Sun; Meng-Shan Tan; Wei Zhang; Hui-Fu Wang; Lan Tan
Journal:  Oncotarget       Date:  2017-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.